Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 805

1.

Central nervous system metastasis in epithelial ovarian carcinoma: a case report and literature review.

Fakour F, Hajizadeh Fallah H, Khajeh Jahromi S, Porteghali P.

J Family Reprod Health. 2015 Mar;9(1):41-4.

2.

Analysis of KRAS and BRAF genes mutation in the central nervous system metastases of non-small cell lung cancer.

Nicoś M, Krawczyk P, Jarosz B, Sawicki M, Szumiłło J, Trojanowski T, Milanowski J.

Clin Exp Med. 2015 Apr 23. [Epub ahead of print]

PMID:
25902737
3.

Central nervous system tumors: Radiologic pathologic correlation and diagnostic approach.

Pant I, Chaturvedi S, Jha DK, Kumari R, Parteki S.

J Neurosci Rural Pract. 2015 Apr-Jun;6(2):191-7. doi: 10.4103/0976-3147.153226.

4.

Unsanctifying the sanctuary: challenges and opportunities with brain metastases.

Puhalla S, Elmquist W, Freyer D, Kleinberg L, Adkins C, Lockman P, McGregor J, Muldoon L, Nesbit G, Peereboom D, Smith Q, Walker S, Neuwelt E.

Neuro Oncol. 2015 May;17(5):639-651. Review.

5.

The occurrence of tumors of the central nervous system in a clinical observation.

Pastuszak Ż, Tomczykiewicz K, Piusińska-Macoch R, Stępień A, Kordowska J.

Pol Merkur Lekarski. 2015 Feb;38(224):88-92.

PMID:
25771517
6.

Primary intracranial Ewing's sarcoma with unusual features.

VandenHeuvel KA, Al-Rohil RN, Stevenson ME, Qian J, Gross NL, McNall-Knapp R, Li S, Wartchow EP, Mierau GW, Fung KM.

Int J Clin Exp Pathol. 2015 Jan 1;8(1):260-74. eCollection 2015.

7.

Neural stem/progenitor cells react to non-glial cns neoplasms.

Campbell JG, Miller DC, Cundiff DD, Feng Q, Litofsky NS.

Springerplus. 2015 Feb 3;4:53. doi: 10.1186/s40064-015-0807-z. eCollection 2015.

8.

Brain metastases in patients with EGFR-mutated or ALK-rearranged non-small-cell lung cancers.

Rangachari D, Yamaguchi N, VanderLaan PA, Folch E, Mahadevan A, Floyd SR, Uhlmann EJ, Wong ET, Dahlberg SE, Huberman MS, Costa DB.

Lung Cancer. 2015 Apr;88(1):108-11. doi: 10.1016/j.lungcan.2015.01.020. Epub 2015 Feb 4.

PMID:
25682925
9.

Improving drug delivery to primary and metastatic brain tumors: Strategies to overcome the blood-brain barrier.

Parrish KE, Sarkaria JN, Elmquist WF.

Clin Pharmacol Ther. 2015 Apr;97(4):336-46. doi: 10.1002/cpt.71. Epub 2015 Feb 18.

PMID:
25669487
10.

The prognostic significance of serum and cerebrospinal fluid MMP-9, CCL2 and sVCAM-1 in leukemia CNS metastasis.

Si MY, Fan ZC, Li YZ, Chang XL, Xie QD, Jiao XY.

J Neurooncol. 2015 Apr;122(2):229-44. doi: 10.1007/s11060-014-1707-8. Epub 2015 Jan 30.

PMID:
25630624
11.

Pattern of metastasis and outcome in patients with breast cancer.

Gerratana L, Fanotto V, Bonotto M, Bolzonello S, Minisini AM, Fasola G, Puglisi F.

Clin Exp Metastasis. 2015 Feb;32(2):125-33. doi: 10.1007/s10585-015-9697-2. Epub 2015 Jan 29.

PMID:
25630269
12.

Intraoperative radiotherapy to treat newly diagnosed solitary brain metastasis: initial experience and long-term outcomes.

Weil RJ, Mavinkurve GG, Chao ST, Vogelbaum MA, Suh JH, Kolar M, Toms SA.

J Neurosurg. 2015 Apr;122(4):825-32. doi: 10.3171/2014.11.JNS1449. Epub 2015 Jan 23.

PMID:
25614945
13.

Expression of proliferation markers Ki67, cyclin A, geminin and aurora-kinase A in primary breast carcinomas and corresponding distant metastases.

Tökés AM, Szász AM, Geszti F, Lukács LV, Kenessey I, Turányi E, Meggyesházi N, Molnár IA, Fillinger J, Soltész I, Bálint K, Hanzély Z, Arató G, Szendröi M, Kulka J.

J Clin Pathol. 2015 Apr;68(4):274-82. doi: 10.1136/jclinpath-2014-202607. Epub 2015 Jan 16.

PMID:
25595275
14.

Hemangioblastoma in the lung: metastatic or primary lesions?

Lu L, Drew PA, Yachnis AT.

Case Rep Pathol. 2014;2014:468671. doi: 10.1155/2014/468671. Epub 2014 Dec 14.

15.

Cytomorphologic and clinicoradiologic analysis of primary nonhematologic central nervous system tumors with positive cerebrospinal fluid.

Ho CY, VandenBussche CJ, Huppman AR, Chaudhry R, Ali SZ.

Cancer Cytopathol. 2015 Feb;123(2):123-35. doi: 10.1002/cncy.21502. Epub 2014 Dec 8.

PMID:
25487367
16.

CNS metastases in breast cancer patients: prognostic implications of tumor subtype.

Bachmann C, Schmidt S, Staebler A, Fehm T, Fend F, Schittenhelm J, Wallwiener D, Grischke E.

Med Oncol. 2015 Jan;32(1):400. doi: 10.1007/s12032-014-0400-2. Epub 2014 Nov 30.

PMID:
25433950
17.

Prognostic Factors in Patients Receiving Third Line Targeted Therapy for Metastatic Renal Cell Carcinoma.

Iacovelli R, Farcomeni A, Sternberg CN, Cartenì G, Milella M, Santoni M, Cerbone L, Di Lorenzo G, Verzoni E, Ortega C, Sabbatini R, Ricotta R, Messina C, Lorusso V, Atzori F, De Vincenzo F, Sacco C, Boccardo F, Valduga F, Massari F, Baldazzi V, Cinieri S, Mosca A, Maria Ruggeri E, Berruti A, Procopio G.

J Urol. 2014 Nov 26. pii: S0022-5347(14)05013-7. doi: 10.1016/j.juro.2014.11.092. [Epub ahead of print]

PMID:
25433306
18.

Platinum sensitivity and CD133 expression as risk and prognostic predictors of central nervous system metastases in patients with epithelial ovarian cancer.

Liu BL, Liu SJ, Baskys A, Cheng H, Han Y, Xie C, Song H, Li J, Xin XY.

BMC Cancer. 2014 Nov 17;14:829. doi: 10.1186/1471-2407-14-829.

19.

First-Line sunitinib in patients with renal cell carcinoma (RCC) in von Hippel-Lindau (VHL) disease: clinical outcome and patterns of radiological response.

Roma A, Maruzzo M, Basso U, Brunello A, Zamarchi R, Bezzon E, Pomerri F, Zovato S, Opocher G, Zagonel V.

Fam Cancer. 2014 Nov 13. [Epub ahead of print]

PMID:
25391617
20.

Preclinical profile of cabazitaxel.

Vrignaud P, Semiond D, Benning V, Beys E, Bouchard H, Gupta S.

Drug Des Devel Ther. 2014 Oct 13;8:1851-67. doi: 10.2147/DDDT.S64940. eCollection 2014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk